The Journal of Chemotherapy (ISSN 1120-009X) is a bi-monthly international peer-reviewed publication based in Italy, issued by Edizioni Eservizi Srl, that serves as a significant forum for advancing knowledge in the field of chemotherapy. The journal encompasses a broad spectrum of research topics, including the development and clinical application of antimicrobial and antineoplastic agents, mechanisms of drug resistance, and novel therapeutic strategies, with a particular emphasis on interdisciplinary approaches that bridge experimental science and clinical practice. By publishing original research articles, comprehensive reviews, and detailed case reports, the journal fosters a rigorous exchange of evidence-based findings that integrate laboratory discoveries with real-world medical applications. As a title indexed in the Science Citation Index (SCI), it maintains a reputable standing within the academic community, though authors and readers are advised to consult the most current data for its specific impact factor and Chinese Academy of Sciences (CAS) journal ranking, as these metrics may fluctuate annually. While the journal adheres to strict editorial standards to ensure high-quality scholarship, it operates under a traditional subscription model rather than being fully open access, making it a valuable resource for researchers, clinicians, and pharmacologists seeking up-to-date insights into the evolving landscape of chemical therapies.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com